Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (288)	11/7/2004 7:23:44 PM
From: tuck	Read Replies (1) \| Respond to of 671

Well, I found it slightly worthwhile, in that it contains a summation of the markets in which the major suppliers are aimed and strong. To answer the lad's vague question: RNAi at this point mostly smoke in terms of therapeutic products, a fire if you're a supplier (but no publicly traded pure plays available). Cheers, Tuck

To: scaram(o)uche who wrote (288)	11/7/2004 9:32:01 PM
From: longorshortofit	Read Replies (1) \| Respond to of 671

Thanks Richard. I expressed no opinion on the report on RNAi, because these things are invariably out of date the minute they are offered for sale. Sometimes the summaries contain something useful. Rather than let it pass unmentioned here, I signed up to SI to let anyone interested in it know it had been advertised. Having familiarity with this board and its contents since last year, I was aware the issue of delivery is rarely mentioned anywhere as an obstacle to be overcome. I apologize for wasting your time.